274 related articles for article (PubMed ID: 30768627)
1. The rs61742690 (S783N) single nucleotide polymorphism is a suitable target for disrupting BCL11A-mediated foetal-to-adult globin switching.
Abdulazeez S; Sultana S; Almandil NB; Almohazey D; Bency BJ; Borgio JF
PLoS One; 2019; 14(2):e0212492. PubMed ID: 30768627
[TBL] [Abstract][Full Text] [Related]
2. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
[TBL] [Abstract][Full Text] [Related]
3. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
[TBL] [Abstract][Full Text] [Related]
4. In-Silico Computing of the Most Deleterious nsSNPs in HBA1 Gene.
AbdulAzeez S; Borgio JF
PLoS One; 2016; 11(1):e0147702. PubMed ID: 26824843
[TBL] [Abstract][Full Text] [Related]
5. Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice.
Esteghamat F; Gillemans N; Bilic I; van den Akker E; Cantù I; van Gent T; Klingmüller U; van Lom K; von Lindern M; Grosveld F; Bryn van Dijk T; Busslinger M; Philipsen S
Blood; 2013 Mar; 121(13):2553-62. PubMed ID: 23361909
[TBL] [Abstract][Full Text] [Related]
6. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.
Sankaran VG; Menne TF; Xu J; Akie TE; Lettre G; Van Handel B; Mikkola HK; Hirschhorn JN; Cantor AB; Orkin SH
Science; 2008 Dec; 322(5909):1839-42. PubMed ID: 19056937
[TBL] [Abstract][Full Text] [Related]
7. [BCL11A represses HbF expression and varies during ontogeny].
Labie D
Med Sci (Paris); 2009 May; 25(5):457-60. PubMed ID: 19480825
[No Abstract] [Full Text] [Related]
8. The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.
Neishabury M; Zamani F; Keyhani E; Azarkeivan A; Abedini SS; Eslami MS; Kakroodi ST; Vesiehsari MJ; Najmabadi H
Blood Cells Mol Dis; 2013 Aug; 51(2):80-4. PubMed ID: 23541515
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effect of single nucleotide polymorphism in Xmn1, BCL11A and HBS1L-MYB loci on foetal haemoglobin levels in β-thalassemia major and Intermedia patients.
Bashir S; Mahmood S; Mohsin S; Tabassum I; Ghafoor M; Sajjad O
J Pak Med Assoc; 2021 May; 71(5):1394-1398. PubMed ID: 34091621
[TBL] [Abstract][Full Text] [Related]
10. Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach.
Fanis P; Kousiappa I; Phylactides M; Kleanthous M
BMC Genomics; 2014 Feb; 15():108. PubMed ID: 24502199
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for human ZBTB7A action at the fetal globin promoter.
Yang Y; Ren R; Ly LC; Horton JR; Li F; Quinlan KGR; Crossley M; Shi Y; Cheng X
Cell Rep; 2021 Sep; 36(13):109759. PubMed ID: 34592153
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the difference in HbF expression due to loss of the 5' δ-globin BCL11A binding region.
Ghedira ES; Lecerf L; Faubert E; Costes B; Moradkhani K; Bachir D; Galactéros F; Pissard S
Haematologica; 2013 Feb; 98(2):305-8. PubMed ID: 22801970
[TBL] [Abstract][Full Text] [Related]
13. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.
Basak A; Hancarova M; Ulirsch JC; Balci TB; Trkova M; Pelisek M; Vlckova M; Muzikova K; Cermak J; Trka J; Dyment DA; Orkin SH; Daly MJ; Sedlacek Z; Sankaran VG
J Clin Invest; 2015 Jun; 125(6):2363-8. PubMed ID: 25938782
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
[TBL] [Abstract][Full Text] [Related]
15. KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching.
Zhou D; Liu K; Sun CW; Pawlik KM; Townes TM
Nat Genet; 2010 Sep; 42(9):742-4. PubMed ID: 20676097
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
17. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
[TBL] [Abstract][Full Text] [Related]
19. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional silencing of fetal hemoglobin by BCL11A.
Sankaran VG; Xu J; Orkin SH
Ann N Y Acad Sci; 2010 Aug; 1202():64-8. PubMed ID: 20712774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]